Novavax
NVAX
#5169
Rank
A$2.19 B
Marketcap
A$13.47
Share price
0.86%
Change (1 day)
12.42%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): A$0.60 Billion

According to Novavax's latest financial reports the company's current earnings are A$1.02 Billion. In 2024 the company made an earning of -A$0.23 Billion, an increase over its 2023 earnings that were of -A$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.60 B-369.65%
2024 -A$0.23 Billion-70.39%
2023 -A$0.77 Billion-16.59%
2022 -A$0.92 Billion-62.58%
2021 -A$2.45 Billion320.54%
2020 -A$0.59 Billion234.22%
2019 -A$0.18 Billion-30.17%
2018 -A$0.25 Billion1.69%
2017 -A$0.25 Billion-36.44%
2016 -A$0.39 Billion70.4%
2015 -A$0.23 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$74.71 Million81.9%
2012 -A$41.07 Million50.33%
2011 -A$27.32 Million
2009 -A$53.92 Million8.8%
2008 -A$49.56 Million18.01%
2007 -A$42 Million18.33%
2006 -A$35.49 Million168.31%
2005 -A$13.23 Million-62.51%
2004 -A$35.29 Million52.4%
2003 -A$23.16 Million-28.21%
2002 -A$32.25 Million
2000 -A$18.38 Million177%
1999 -A$6.64 Million-11.54%
1998 -A$7.5 Million10.64%
1997 -A$6.78 Million-9.62%
1996 -A$7.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.58 B 4,260.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.69 B 2,617.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.34 B 3,662.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.27 B 2,538.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.37 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.42 Billion-176.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$29.8 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.72 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.38 B-28.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA